| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/15/1997 | WO1997017077A1 Topical composition containing capsazepine |
| 05/15/1997 | WO1997017075A1 Topical foamable pharmaceutical composition for treating skin diseases induced by oval pityrosporum |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | WO1997017065A1 Cellulose acetate phthalate enteric coating compositions |
| 05/15/1997 | WO1997017064A1 Stable freeze-dried pharmaceutical formulation |
| 05/15/1997 | WO1997017063A1 Microencapsulated dna for vaccination and gene therapy |
| 05/15/1997 | WO1997017062A1 Pharmaceutical composition for topical application |
| 05/15/1997 | WO1997017061A1 Therapeutic preparation for the transdermal administration of active substances |
| 05/15/1997 | DE3690626C2 Medicinal compsn. for trans-dermal use |
| 05/15/1997 | DE19541679A1 Gene transfer systems containing nuclear localisation sequences and or magnetisable microparticles, |
| 05/15/1997 | CA2234797A1 Topical composition containing capsazepine |
| 05/14/1997 | EP0773441A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 05/14/1997 | EP0773229A1 Cyclodextrin derivatives and their use, especially in cosmetics |
| 05/14/1997 | EP0773034A1 Biodegradable in-situ forming implants |
| 05/14/1997 | EP0773028A1 Percutaneously absorbable preparation |
| 05/14/1997 | EP0773025A1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0773020A2 Pharmaceutical compositions containing L-carnitine or derivatives thereof in combination with resveratrol or derivatives thereof, for the prophylaxis and treatment of cardiovascular disorders, peripheral vascular diseases and peripheral diabetic neuropathy |
| 05/14/1997 | EP0773018A1 Cosmetic and/or pharmaceutical emulsions |
| 05/14/1997 | EP0773017A1 Cosmetic and/or pharmaceutical emulsions |
| 05/14/1997 | EP0773012A1 Means for atomizing mineral water |
| 05/14/1997 | EP0772776A1 Superparamagnetic particles, process for their production and their use |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772465A1 Alginate fibres, manufacture and use |
| 05/14/1997 | EP0772463A1 Alginate fibre, process for the preparation thereof and use |
| 05/14/1997 | EP0772462A1 Alginate fibres, method of preparation and use |
| 05/14/1997 | EP0772452A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix |
| 05/14/1997 | EP0772445A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 05/14/1997 | EP0772443A1 Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease |
| 05/14/1997 | EP0772436A1 Incorporation of biologically active molecules into bioactive glasses |
| 05/14/1997 | EP0772435A1 Controlled release of metal cation-stabilized interferon |
| 05/14/1997 | EP0772434A1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
| 05/14/1997 | EP0536255B1 Ophthalmic suspensions |
| 05/14/1997 | EP0414920B1 Aerosol preparation for external use |
| 05/14/1997 | CN1149835A Group A streptococcal polysaccharide immunogenic compositions and methods |
| 05/14/1997 | CN1149834A Cyclosporin containing composition and process for preparation |
| 05/14/1997 | CN1149832A Solid antacid and process for producing the same |
| 05/14/1997 | CN1149831A Controlled-release dosage forms of azithromycin |
| 05/14/1997 | CN1149830A Pyridylbisphosphonates for use as therapeutical agent |
| 05/14/1997 | CN1149829A Polymer coated tablet comprising amoxycillin and clavulanate |
| 05/14/1997 | CN1149826A Active substance carrier for controlled release of active substance in gastro-intestinal tract with delayed passage through pylorus |
| 05/14/1997 | CN1149824A Method for preparation of pearls and pearls obtained containing active ingredient with undefined melting point |
| 05/14/1997 | CN1149492A Technology for producing strengthening waist and invigorating kidney oral liquor |
| 05/14/1997 | CN1149487A Health oral liquor for refreshing shen and invigorating qi and its preparation method |
| 05/14/1997 | CN1149486A Contraceptive hemostatic and its preparation method |
| 05/14/1997 | CN1149485A Cynanchum otophyllum for anti-Meniere's disease, usage and preparation method |
| 05/14/1997 | CN1149482A Nutritive liquid for male |
| 05/14/1997 | CN1149481A Capsule for enhancing eyesight |
| 05/14/1997 | CN1149478A Concentrated powder for colitis |
| 05/14/1997 | CN1149477A Medicine for curing corn and its preparation method |
| 05/14/1997 | CN1149472A Nutritive preparation for computer operator and its production technology |
| 05/14/1997 | CN1149469A Oral preparation for rhinitis |
| 05/14/1997 | CN1149468A Powder for laryngopharyngitis |
| 05/14/1997 | CN1149467A Rhinitis oil paint |
| 05/14/1997 | CN1149466A Chinese herbal medicine burn-healing preparation and its preparing method |
| 05/14/1997 | CN1149465A Traditional Chinese medicine metabolic powder |
| 05/14/1997 | CN1149464A New matrix magnetic therapeutic anesthesia analgesic paste |
| 05/14/1997 | CN1149463A Preparation method for recovering bag of child anorexia |
| 05/14/1997 | CN1149460A Chicken bile oral liquor |
| 05/13/1997 | US5629333 Method treating cognitive disorders using optically pure R(+) ondansetron |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629316 Stabilized solid pharmaceutical preparation and method of producing the same |
| 05/13/1997 | US5629303 Controlled release systems and low dose androgens |
| 05/13/1997 | US5629302 Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for the treatment of tumors |
| 05/13/1997 | US5629297 Administering ranitidine bismuth citrate and helicobacter inhibiting antibiotics |
| 05/13/1997 | US5629292 Use of angiotensin III and analogs thereof in tissue repair |
| 05/13/1997 | US5629282 Antibacterial compositions |
| 05/13/1997 | US5629281 To relieve headache pain |
| 05/13/1997 | US5629090 Starch hydrolysates as sequesterers |
| 05/13/1997 | US5629022 Galenic medicine in shaped form, able to be sucked or administered sublingually: porous, crosslinked, edible substrate; hydrophilic hydrocolloid polymer gel network in substrate; active product microcrystal dispersion |
| 05/13/1997 | US5629021 Drug delivery |
| 05/13/1997 | US5629020 Delivery of sensitive agents such as bioactive peptides |
| 05/13/1997 | US5629018 Composition for controlled release of an active substance and method for the preparation of such a composition |
| 05/13/1997 | US5629017 Programmed release oral solid pharmaceutical dosage form |
| 05/13/1997 | US5629016 Water-dispersible tablets |
| 05/13/1997 | US5629014 Foam laminate transdermal patch |
| 05/13/1997 | US5629013 Chewable calcium carbonate antacid tablet compositions |
| 05/13/1997 | US5629012 Uniform drug delivery |
| 05/13/1997 | US5629011 Absorption promoters for derivatives of opioid analgesics |
| 05/13/1997 | US5629009 Inducing chondrogenesis and osteogenesis by implanting shaped polyanhydride or polyorthoester matrix with bioactive substance, i.e., demineralized bone protein, tgf-beta, egf, fgf or pdgf |
| 05/13/1997 | US5629008 Method and device for long-term delivery of drugs |
| 05/13/1997 | US5629003 Rapidly disintegrating sheet-like presentations of multiple dosage units |
| 05/13/1997 | US5629001 Oral administration of therapeutic proteins for treatment of infectious disease |
| 05/13/1997 | US5628993 Interferon and polyglycerol diester of stearic acid or palmitic acid |
| 05/13/1997 | US5628984 Composition to promote lung mucus secretions |
| 05/13/1997 | US5628981 Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
| 05/13/1997 | US5628930 Stabilization of fluorocarbon emulsions |
| 05/13/1997 | CA2132045C Pharmaceutical composition for prophylaxis and treatment of premature ejaculation |
| 05/13/1997 | CA2039247C Multiple encapsulated flavor delivery system and method of preparation |
| 05/09/1997 | WO1997016463A1 Polymers comprising reversible hydrophobic functionalities |
| 05/09/1997 | WO1997016212A1 Water soluble films |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016195A1 Wettable powder compositions of ionophore antibiotics |
| 05/09/1997 | WO1997016178A1 Stabilised pharmaceutical preparations containing thyroid hormone |
| 05/09/1997 | WO1997016176A1 Angiogenic material and uses thereof |
| 05/09/1997 | WO1997016175A1 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 05/09/1997 | WO1997016174A1 Process for aqueous granulation of clarithromycin |
| 05/09/1997 | WO1997016173A1 New technology for wet granulation |
| 05/09/1997 | WO1997016172A1 Controlled release formulation (albuterol) |